Arrestin-mediated activation of p38 MAPK: Molecular mechanisms and behavioral consequences

Handbook of Experimental Pharmacology

Volumn 219, Issue , 2014, Pages 281-292

  Chavkin, Charles ^a   Schattauer, Selena S ^a   Levin, Jamie R ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Arrestin; Dynorphin; Kappa opioid receptor; p38 MAPK

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; DYNORPHIN; G PROTEIN COUPLED RECEPTOR KINASE 3; KAPPA OPIATE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 14; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; POTASSIUM CHANNEL; POTASSIUM CHANNEL KIR3; SEROTONIN; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR3; ION CHANNEL; RETINA S ANTIGEN;

ARTICLE; ASTROCYTE; CELL ACTIVATION; CELLULAR STRESS RESPONSE; COMPLEX FORMATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HORMONE RELEASE; HUMAN; NERVE CELL INHIBITION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; ENZYME MECHANISM;

ANIMALS; ARRESTINS; DRUG DESIGN; GTP-BINDING PROTEIN BETA SUBUNITS; GTP-BINDING PROTEIN GAMMA SUBUNITS; HUMANS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RECEPTORS, OPIOID, KAPPA; SIGNAL TRANSDUCTION;

EID: 84958539903     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/978-3-642-41199-1_14     Document Type: Article

References (53)

1. Akil H, Meng F, Mansour A, Thompson R, Xie GX, Watson S (1996) Cloning and characterization of multiple opioid receptors. NIDA Res Monogr 161:127-40
2. Appleyard SM, Celver J, Pineda V, Kovoor A, Wayman GA, Chavkin C (1999) Agonistdependent desensitization of the kappa opioid receptor by G protein receptor kinase and ?-arrestin. J Biol Chem 274:23802-23807
3. Breitman M, Kook S, Gimenez LE, Lizama BN, Palazzo MC, Gurevich EV, Gurevich VV (2012) Silent scaffolds: inhibition of c-Jun N-terminal kinase 3 activity in cell by dominant-negative arrestin-3 mutant. J Biol Chem 287:19653-19664
4. Bruchas MR, Chavkin C (2010) Kinase cascades and ligand-directed signaling at the kappa opioid receptor. Psychopharmacology (Berl) 210:137-147
5. BruchasMR,Macey TA, Lowe JD,ChavkinC (2006)Kappa opioid receptor activation of p38MAPK is GRK3-and arrestin-dependent in neurons and astrocytes. J Biol Chem 281:18081-18089
6. Bruchas MR, Land BB, Aita M, Xu M, Barot SK, Li S, Chavkin C (2007a) Stress-induced p38 mitogen-activated protein kinase activation mediates kappa-opioid-dependent dysphoria. J Neurosci 27:11614-11623
7. Bruchas MR, Yang T, Schreiber S, Defino M, Kwan SC, Li S, Chavkin C (2007b) Long-acting kappa opioid antagonists disrupt receptor signaling and produce noncompetitive effects by activating c-Jun N-terminal kinase. J Biol Chem 282:29803-29811
8. Bruchas MR, Xu M, Chavkin C (2008) Repeated swim-stress induces kappa opioid-mediated activation of ERK1/2 MAPK. Neuroreport 19(14):1417-1422
9. Bruchas MR, Land BB, Lemos JC, Chavkin C (2009) CRF1-R activation of the dynorphin/kappa opioid system in the mouse basolateral amygdala mediates anxiety-like behavior. PLoS One 4 (12):e8528
10. Bruchas MR, Schindler AG, Shankar H, Messinger DI, Miyatake M, Land BB, Lemos JC, Hagen C, Neumaier JN, Quintana A, Palmiter RD, Chavkin C (2011) Selective p38alpha MAPK deletion in serotonergic neurons produces stress-resilience in models of depression and addiction. Neuron 71:498-511
11. Burack WR, Shaw AS (2000) Signal transduction. Hanging on a scaffold. Curr Opin Cell Biol 12:211-216
12. Chavkin C, James IF, Goldstein A (1982) Dynorphin is a specific endogenous ligand of the kappa opioid receptor. Science 215:413-415
13. Chavkin C (2011) The therapeutic potential of kappa opioids for treatment of pain and addiction. Neuropsychopharmacology 36:369-370
14. Cherubini E, North RA (1985) Mu and kappa opioids inhibit transmitter release by different mechanisms. Proc Natl Acad Sci USA 82:1860-1863
15. Clayton CC, Xu M, Chavkin C (2009) Tyrosine phosphorylation of Kir3 following kappa opioid receptor activation of p38-MAPK causes heterologous desensitization. J Biol Chem 284:31872-31881
16. Daaka Y, Luttrell LM, Lefkowitz RJ (1997) Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A. Nature 390:88-91
17. Dang VC, Christie MJ (2012) Mechanisms of rapid opioid receptor desensitization, resensitization and tolerance in brain neurons. Br J Pharmacol 165:1704-1716
18. De Wire SM, Ahn S, Lefkowitz RJ, Shenoy SK (2007) Beta-arrestins and cell signaling. Annu Rev Physiol 69:483-510
19. Gesty P. D, Flannery P, Yuan L, Corsino L, Spurney R, Lefkowitz RJ, Luttrell LM (2009) A beta-arrestin-biased agonist of the parathyroid hormone receptor (PTH1R) promotes bone formation independent of G protein activation. Sci Transl Med 1:1ra1
20. Grudt TJ, Williams JT (1995) Opioid receptors and the regulation of ion conductances. Rev Neurosci 6:279-286
21. Hahn JW, Jagwani S, Kim E, Rendell VR, He J, Ezerskiy LA, Wesselschmidt R, Coscia CJ, Belcheva MM (2010) Mu and kappa opioids modulate mouse embryonic stem cell-derived neural progenitor differentiation via MAP kinases. J Neurochem 112:1431-141
22. Herlitze S, Garcia DE, Mackie K, Hille B, Scheuer T, Catterall WA (1996) Modulation of Ca2+ channels by G-protein beta gamma subunits. Nature 380:258-262
23. Ippolito DL, Temkin PA, Rogalski SL, Chavkin C (2002) N-terminal tyrosine residues within the potassium channel Kir3 modulate GTPase activity of Galphai. J Biol Chem 277:32692-32696
24. Ippolito DL, Xu M, Bruchas MR, Wickman K, Chavkin C (2005) Tyrosine phosphorylation of K (ir)3.1 in spinal cord is induced by acute inflammation, chronic neuropathic pain, and behavioral stress. J Biol Chem 280:41683-41693
25. Land BB, Bruchas MR, Lemos JC, Xu M, Melief EJ, Chavkin C (2008) The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system. J Neurosci 28:407-414
26. Lemos JC, Roth CA, Messinger DI, Gill HK, Phillips PEM, Chavkin C (2012) Repeated stress exposure dysregulates kappa opioid receptor signaling in the dorsal raphe through a p38? MAPK dependent mechanism. J Neurosci 32:12325-12336
27. Li J, Li JG, Chen C, Zhang F, Liu-Chen LY (2002) Molecular basis of differences in (-)(trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidiny)-cyclohexyl] benzeneacetamide-induced desensitization and phosphorylation between human and rat kappa-opioid receptors expressed in Chinese hamster ovary cells. Mol Pharmacol 61:73-84
28. Luttrell LM, Ferguson SS, Daaka Y, Miller WE, Maudsley S, Della Rocca GJ, Lin F, Kawakatsu H, Owada K, Luttrell DK, Caron MG, Lefkowitz RJ (1999) Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. Science 283:655-661
29. McDonald PH, Chow CW, Miller WE, Laporte SA, Field ME, Lin FT, Davis RJ, Lefkowitz RJ (2000) Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3. Science 290:1574-1577
30. McLaughlin JP, Xu M, Mackie K, Chavkin C (2003) Phosphorylation of a carboxy-terminal serine within the kappa opioid receptor produces desensitization and internalization. J Biol Chem 278:34631-34640
31. McLaughlin JP, Land BB, Li S, Pintar JE, Chavkin C (2006) Prior activation of kappa opioid receptors by U50,488 mimics repeated forced swim stress to potentiate cocaine place preference conditioning. Neuropsychopharmacology 31:787-794
32. McLennan GP, Kiss A, Miyatake M, Belcheva MM, Chambers KT, Pozek JJ, Mohabbat Y, Moyer RA, Bohn LM, Coscia CJ (2008) Kappa opioids promote the proliferation of astrocytes via Gbetagamma and beta-arrestin 2-dependent MAPK-mediated pathways. J Neurochem 107:1753-1765
33. Melief EJ, Miyatake M, Bruchas MR, Chavkin C (2010) Ligand-directed Jun kinase activation disrupts opioid receptor signaling. Proc Natl Acad Sci USA 107:11608-11613
34. Miller WE, Houtz DA, Nelson CD, Kolattukudy PE, Lefkowitz RJ (2003) G-protein-coupled receptor (GPCR) kinase phosphorylation and beta-arrestin recruitment regulate the constitutive signaling activity of the human cytomegalovirus US28 GPCR. J Biol Chem 278:21663-21671
35. Morris GE, Nelson CP, Brighton PJ, Standen NB, Challiss RA, Willets JM (2012) Arrestins 2 and 3 differentially regulate ETA and P2Y2 receptor-mediated cell signaling and migration in arterial smooth muscle. Am J Physiol Cell Physiol 302:C723-34.
36. Pearson G, Robinson F, Beers GT, Xu BE, Karandikar M, Berman K, Cobb MH 2001) Mitogenactivated protein (MAP) kinase pathways. Regulation and physiological functions. Endocr Rev 22 153-183
37. Pfeiffer A, Brantl V, Herz A, Emrich HM (1986) Psychotomimesis mediated by kappa opiate receptors. Science 233:774-776
38. Rives ML, Rossillo M, Liu-Chen LY, Javitch JA (2012) 6'- Guanidinonaltrindole (6'-GNTI) is a G protein-biased opioid receptor agonist that inhibits arrestin recruitment. J Biol Chem 287:27050-27054
39. Samuvel DJ, Jayanthi LD, Bhat NR, Ramamoorthy S (2005) A role for p38 mitogen-activated protein kinase in the regulation of the serotonin transporter: evidence for distinct cellular mechanisms involved in transporter surface expression. J Neurosci 25:29-41
40. Schattauer SS, Miyatake M, Shankar H, Zietz C, Levin JR, Liu-Chen LY, Gurevich VV, Rieder MJ, Chavkin C (2012) Ligand directed signaling differences between rodent and human kappa opioid receptors. J Biol Chem 287:41595-41607
41. Schindler AG, Messinger DI, Smith JS, Shankar H, Gustin RM, Schattauer SS, Lemos JC, Chavkin NW, Hagan CE, Neumaier JN, Chavkin C (2012) Stress produces aversion and potentiates cocaine reward by releasing endogenous dynorphins in the ventral striatum to locally stimulate serotonin reuptake. J Neurosci 32:17582-17596
42. Shippenberg TS, Herz A (1986) Differential effects of mu and kappa opioid systems on motivational processes. NIDA Res Monogr 75:563-66
43. Simmons ML, Chavkin C (1996) Endogenous opioid regulation of hippocampal function. Int Rev Neurobiol 39:145-196
44. Sun Y, Cheng Z, Ma L, Pei G (2002) Beta-arrestin2 is critically involved in CXCR4-mediated chemotaxis, and this is mediated by its enhancement of p38 MAPK activation. J Biol Chem 277:49212-49219
45. Urban JD, Clarke WP, von Zastrow M, Nichols DE, Kobilka B, Weinstein H, Javitch JA, Roth BL, Christopoulos A, Sexton PM, Miller KJ, Spedding M, Mailman RB (2007) Functional selectivity and classical concepts of quantitative pharmacology. J Pharmacol Exp Ther 320:1-13
46. Violin JD, DeWire SM, Yamashita D, Rominger DH, Nguyen L, Schiller K, Whalen EJ, Gowen M, Lark MW (2010) Selectively engaging beta-arrestins at the angiotensin II type 1 receptor reduces blood pressure and increases cardiac performance. J Pharmacol Exp Ther 335:572-579
47. Wang Z, Gardell LR, Ossipov MH, Vanderah TW, Brennan MB, Hochgeschwender U, Hruby VJ, Malan TP Jr, Lai J, Porreca F (2001) Pronociceptive actions of dynorphin maintain chronic neuropathic pain. J Neurosci 21:1779-1786
48. Werz MA, Macdonald RL (1984) Dynorphin reduces voltage-dependent calcium conductance of mouse dorsal root ganglion neurons. Neuropeptides 5:253-256
49. Xu M, Petraschka M, McLaughlin JP, Westenbroek R, Caron MG, Lefkowitz RJ, Czyzyk TA, Pintar JE, Chavkin C (2004) Neuropathic pain activates the endogenous kappa opioid system in mouse spinal cord and induces opioid receptor tolerance. J Neurosci 24:4576-4584
50. Xu M, Bruchas MR, Ippolito DL, Gendron L, Chavkin C (2007) Sciatic nerve ligation-induced proliferation of spinal cord astrocytes is mediated by kappa opioid activation of p38 Mitogen-Activated Protein Kinase. J Neurosci 27:2570-2581
51. Yang X, Zhou G, Ren T, Li H, Zhang Y, Yin D, Qian H, Li Q (2012) ?-Arrestin prevents cell apoptosis through pro-apoptotic ERK1/2 and p38 MAPKs and anti-apoptotic Akt pathways. Apoptosis 17:1019-1026
52. Zhu CB, Hewlett WA, Feoktistov I, Biaggioni I, Blakely RD (2004) Adenosine receptor, protein kinase G, and p38 mitogen-activated protein kinase-dependent up-regulation of serotonin transporters involves both transporter trafficking and activation. Mol Pharmacol 65:1462-1474
53. Zhu CB, Carneiro AM, Dostmann WR, Hewlett WA, Blakely RD (2005) p38 MAPK activation elevates serotonin transport activity via a trafficking-independent, protein phosphatase 2A-dependent process. J Biol Chem 280:15649-15658